Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Odevixibat in Children With Biliary Atresia (BOLD-EXT)
NCT05426733Phase 3Active, not recruiting
- Sponsor
- Ipsen
- Start
- Jul 2022
- Primary completion
- Oct 2026
- Modality
- Small Molecules
- Countries
- 14
01
Overview
A Phase 3 trial of odevixibat in biliary atresia, sponsored by Ipsen. Started Jul 2022; status: active, not recruiting.
02
Drugs
odevixibat
03
Conditions
biliary atresia
Beyond the preview
Go deeper on NCT05426733.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05426733.